The relationships between mild cognitive impairment and phenotype in Parkinson's disease (Q33917203)

30 July 2017

The relationships between mild cognitive impairment and phenotype in Parkinson's disease (English)

1 reference

mild cognitive impairment

30 July 2017

1 reference

1 reference

cognitive dysfunction

1 reference

Courtney C Walton

4

0 references

Claire O'Callaghan

Claire O'Callaghan

2

0 references

James M. Shine

James M Shine

3

0 references

Sharon L. Naismith

Sharon L Naismith

6

0 references

Glenda Halliday

Glenda M Halliday

7

0 references

Simon J.G. Lewis

8

Simon Jg Lewis

1 reference

30 July 2017

5

Loren Mowszowski

1 reference

30 July 2017

1

Jennifer Yy Szeto

1 reference

PubMed ID

28725684

30 July 2017

language of work or name

1 reference

27 August 2015

1 reference

30 July 2017

NPJ Parkinson's disease

1 reference

30 July 2017

1

1 reference

30 July 2017

15015

1 reference

Creative Commons Attribution 4.0 International

30 July 2017

start time

27 August 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/npjparkd.2015.15

0 references

cites work

Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

The Next Step: A Common Neural Mechanism for Freezing of Gait

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Impaired cognitive control in Parkinson's disease patients with freezing of gait in response to cognitive load

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Premotor and nonmotor features of Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

The neurobiological basis of cognitive impairment in Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Functional brain imaging of cognitive dysfunction in Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Noradrenaline and Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Excessive daytime sleepiness in patients with Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

The cholinergic system and Parkinson disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

A clinico-pathological study of subtypes in Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Brainstem pathology and non-motor symptoms in PD.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Dopamine modulates persistent synaptic activity and enhances the signal-to-noise ratio in the prefrontal cortex

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

The association between motor subtypes and psychopathology in Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Range of neuropsychiatric disturbances in patients with Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Clinical heterogeneity in newly diagnosed Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

The heterogeneity of cognitive symptoms in Parkinson's disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Early phenotypic differences between Parkinson's disease patients with and without freezing of gait.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Restricted disease propagation in multiple system atrophy with prolonged survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

Assessment of sleep and sleepiness in Parkinson disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516553

Clinical predictors in Parkinson's disease

29 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2015.15

inferred from DOI database lookup

7 January 2021

based on heuristic

Age of disease onset influences cognition in Parkinson's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28725684

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NPJPARKD.2015.15

1 reference

PubMed ID

28725684

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference

PubMed ID

28725684